Octapharma S.A.
SpainAll drugs from this manufacturer
-
It is used to restore and maintain circulating blood volume in patients presenting with a deficiency of it.
Dosage form: solution for infusion
Active substance Dosage human albumin 200 g -
It is used to restore and maintain circulating blood volume in patients presenting with a deficiency of this.
Dosage form: solution for infusion
Active substance Dosage human albumin 50 g -
It is used to treat people with a congenital deficiency of antithrombin, in order to prevent the formation and development of clots in the deep veins (deep vein thrombosis) and embolisms in high-risk situations, such as during surgery or childbirth.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage human antithrombin iii 1000 UI -
It is used to treat patients with congenital antithrombin deficiency, in order to prevent the formation and development of clots in the deep veins (deep vein thrombosis) and embolisms in high-risk situations, such as surgery or childbirth.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage human antithrombin iii 500 UI -
It is used to treat bleeding episodes and to prevent hemorrhages during surgery in individuals with congenital fibrinogen deficiency. It is also used to supplement fibrinogen in patients with severe uncontrolled bleeding caused by an acquired deficiency of this protein during surgery.
Dosage form: powder and solvent for solution for injection and for infusion
Active substance Dosage human fibrinogen 1 g -
It is used to treat people with antibody deficiency (whether congenital or acquired due to diseases or treatments), to protect children and adolescents exposed to measles when they cannot be vaccinated, and to treat certain autoimmune diseases such as Kawasaki disease, Guillain-Barré syndrome, or immune thrombocytopenia.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used as replacement therapy in children, adolescents, and adults with antibody deficiency (either inherited or acquired due to diseases or treatments). It is also used to protect vulnerable individuals exposed to measles and to treat certain autoimmune disorders such as Kawasaki disease, Guillain-Barré syndrome, immune thrombocytopenia (ITP), and other nervous system conditions.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 50 mg -
It is used to treat and prevent bleeding in patients with hemophilia A, a hereditary disease caused by a deficiency of coagulation factor VIII.
Dosage form: powder and solvent for solution for injection
Active substance Dosage human factor viii 500 UI -
It is used to treat and prevent bleeding in people with hemophilia A, a disease caused by a deficiency of coagulation factor VIII.
Dosage form: powder and solvent for solution for injection
Active substance Dosage human factor viii 1000 UI -
It is used to treat and prevent bleeding in people with hemophilia B, a blood disorder caused by a deficiency of coagulation factor IX in the blood.
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor ix 100 UI -
It is used to treat complex coagulation factor deficiencies caused by severe liver failure or massive transfusion. It is also used to rapidly reverse the effects of certain oral anticoagulants in emergencies or to restore coagulation factor balance in patients undergoing plasma exchange.
Dosage form: solution for infusion
Active substance Dosage human plasma protein 9-14 g -
It is used to treat coagulation factor deficiencies caused by severe liver failure or massive transfusions. It is also used to rapidly reverse the effects of certain oral anticoagulants in emergencies or to restore coagulation balance in patients undergoing plasma exchange.
Dosage form: solution for infusion
Active substance Dosage human plasma protein 9-14 g -
It is used to treat coagulation factor deficiencies caused by severe liver failure or massive transfusion. It is also used to rapidly reverse the effects of certain oral anticoagulants in emergencies or to restore coagulation balance in patients undergoing plasma exchange.
Dosage form: solution for infusion
Active substance Dosage human plasma protein 9-14 g -
It is used to treat coagulation factor deficiencies caused by severe liver failure or massive transfusion. It is also used to rapidly reverse the effects of certain oral anticoagulants in emergencies or to restore coagulation balance in patients undergoing plasma exchange.
Dosage form: solution for infusion
Active substance Dosage human plasma protein 9-14 g -
It is used to treat and prevent bleeding caused by vitamin K antagonists (such as warfarin) when rapid correction of the deficiency is required. It is also used in individuals born with a deficiency of coagulation factors II and X, when a specific purified coagulation factor product is not available.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage factor ii 14-38 UI factor vii 9-24 UI factor ix 25 UI factor x 18-30 UI protein c 13-31 UI protein s 12-32 UI -
It is used to treat and prevent bleeding caused by vitamin K antagonists (such as warfarin) when rapid correction of coagulation deficiency is required. It is also used in individuals born with a deficiency of coagulation factors II and X, when a specific purified product is not available.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage factor ii 11-38 UI factor vii 9-24 UI factor ix 25 UI factor x 18-30 UI plasma proteins 7-31 UI plasma proteins 7-32 UI -
It is used as replacement therapy for individuals with antibody deficiency (whether congenital or secondary) and to protect vulnerable children and adolescents exposed to measles. It is also used to treat certain autoimmune disorders such as immune thrombocytopenia (ITP), Kawasaki disease, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat and prevent bleeding in people with von Willebrand disease or hemophilia A.
Dosage form: powder and solvent for solution for injection
Active substance Dosage human factor viii 100 UI human von willebrand factor 100 UI -
It is used to treat and prevent bleeding in people with von Willebrand disease or hemophilia A.
Dosage form: powder and solvent for solution for injection
Active substance Dosage human factor viii 100 UI human von willebrand factor 100 UI